Literature DB >> 1826959

Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II.

J D Chapman1, C C Stobbe, M R Arnfield, R Santus, J Lee, M S McPhee.   

Abstract

Asynchronous populations of mouse EMT-6 tumor cells were treated with Photofrin II and exposed to various doses of 630 nm light in slowly stirred suspensions which had been equilibrated with various concentrations of oxygen. Survival curves were generated with cells exposed to 20 micrograms/ml Photofrin II in tissue culture medium for 1 h, a procedure which made it possible to remove more than 50% of the drug by washing. It is expected that under these conditions the drug would be loosely bound to cell surface and plasma membranes and in the cellular cytosol. Survival curves were also generated with cells exposed to 5 micrograms/ml Photofrin II for 20-24 h, a procedure which resulted in greater than 90% of the drug being tightly bound within cells, presumably to cellular lipids and membranes. Oxygen was obligatory for killing cells which had been exposed for both "short term" and "long term" to Photofrin II. After 30-40 min of pregassing cells with nitrogen gas which contained precise levels of oxygen, the concentration required to reduce rates of cell killing to 50% of maximum was approximately 0.5% O2 (gas phase) for short-term drug exposures and less than or equal to 0.05% O2 for long-term drug exposures. Even after pregassing times of 90-120 min prior to light administration, a Km of approximately equal to 0.1% O2 was observed for cells exposed to the drug for the longer time. When the same cells were exposed to 137Cs gamma rays in this irradiation chamber, no change in radiation sensitivity was observed after 30 min of pregassing cells with all oxygen concentrations studied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826959

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

Review 1.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

2.  Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.

Authors:  J D Chapman; L R Coia; C C Stobbe; E L Engelhardt; M C Fenning; R F Schneider
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 3.  Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.

Authors:  Zijian Zhou; Jibin Song; Liming Nie; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-11-21       Impact factor: 54.564

4.  Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid.

Authors:  Rod D Braun; Asad Abbas; S Omar Bukhari; Willie Wilson
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

5.  Effects of the oxygenation level on formation of different reactive oxygen species during photodynamic therapy.

Authors:  Michael Price; Lance Heilbrun; David Kessel
Journal:  Photochem Photobiol       Date:  2013-01-25       Impact factor: 3.421

Review 6.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

7.  The effects of hyperoxic and hypercarbic gases on tumour blood flow.

Authors:  T J Dunn; R D Braun; W E Rhemus; G L Rosner; T W Secomb; G M Tozer; D J Chaplin; M W Dewhirst
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

8.  Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.

Authors:  I P van Geel; H Oppelaar; P F Rijken; H J Bernsen; N E Hagemeier; A J van der Kogel; R J Hodgkiss; F A Stewart
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.